Sesh Products US, Inc. (Sesh) today announced that the U.S. Food and Drug Administration (FDA) has determined that its bundled Premarket Tobacco Product Application (PMTA) submission, covering 64 SKUs ...
CEO Richard Adcock used a presentation at the Citizens Life Sciences Conference to outline the company’s commercial progress ...
MIRA trial data demonstrated a 43% response with 120mg SLK, and a 29 ppt delta vs placebo (p < 0.001) at week 12. VELA-1 met all primary and key secondary endpoints with statistical significance ...
Here is a fact that should reframe how you think about Insmed (NASDAQ:INSM) and its lung disease franchise: Japan has more ...
Stocktwits on MSN
Cingulate stock jumps overnight: US Patent Office clears ADHD drug filing ahead of May FDA catalyst
The USPTO cleared a patent filed in November 2023, with a status indicating it has been approved and the patent is expected to be issued. ・The filing covers drug-delivery technologies for neurological ...
Calgary, Alberta--(Newsfile Corp. - September 23, 2025) - Hemostemix Inc. (HEM:CA) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ ...
WASHINGTON, Feb. 25, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of its Biologics License ...
There is strong demand for compassionate use of OST-HER2 from the patient community, underscoring the urgent need for new therapies in Human Metastatic Osteosarcoma.” — Paul Romness, MPH, Chairman & ...
Sanofi SNY announced that the FDA has accepted a regulatory filing seeking to expand the use of its type 1 diabetes (T1D) drug, Tzield (teplizumab), in individuals aged one year and older. The agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results